We are live on ! Find out more
RYZB

RayzeBio, Inc. Common Stock
RYZB

Delisted

RYZB was delisted on the 23rd of February, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in RayzeBio, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 107 → 0 (-107)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less capital invested

Capital invested by funds: $3.41B → $0 (-$3.41B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 106

Holders
–
Holders Change
-107
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
106
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$413M
2
VP
venBio Partners
California
-$321M
3
VVM
Versant Venture Management
California
-$321M
4
VA
VR Adviser
New York
-$251M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$216M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
76
Wolverine Asset Management
Illinois
– -$727K -11,700 Closed
T. Rowe Price Associates
77
T. Rowe Price Associates
Maryland
– -$690K -11,086 Closed
MIM
78
MetLife Investment Management
New Jersey
– -$677K -10,892 Closed
AIG
79
American International Group
New York
– -$621K -9,987 Closed
Deutsche Bank
80
Deutsche Bank
Germany
– -$619K -9,962 Closed
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
– -$558K -8,969 Closed
Invesco
82
Invesco
Georgia
– -$555K -8,924 Closed
SC
83
Sagefield Capital
Texas
– -$553K -8,900 Closed
SG Americas Securities
84
SG Americas Securities
New York
– -$506K -8,138 Closed
VOYA Investment Management
85
VOYA Investment Management
Georgia
– -$476K -7,657 Closed
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$473K -7,612 Closed
M&T Bank
87
M&T Bank
New York
– -$466K -7,480 Closed
Goldman Sachs
88
Goldman Sachs
New York
– -$439K -7,062 Closed
Royal Bank of Canada
89
Royal Bank of Canada
Ontario, Canada
– -$395K -6,349 Closed
GI
90
GAMCO Investors
Connecticut
– -$376K -6,050 Closed
Wells Fargo
91
Wells Fargo
California
– -$356K -5,722 Closed
SO
92
STRS Ohio
Ohio
– -$267K -4,300 Closed
Victory Capital Management
93
Victory Capital Management
Texas
– -$252K -4,055 Closed
XT
94
XTX Topco
Cayman Islands
– -$250K -4,027 Closed
VEA
95
Virtus ETF Advisers
New York
– -$216K -3,481 Closed
ProShare Advisors
96
ProShare Advisors
Maryland
– -$207K -3,326 Closed
California State Teachers Retirement System (CalSTRS)
97
California State Teachers Retirement System (CalSTRS)
California
– -$206K -3,307 Closed
Citigroup
98
Citigroup
New York
– -$177K -2,854 Closed
AB
99
Amalgamated Bank
New York
– -$146K -2,347 Closed
AIP
100
Ameritas Investment Partners
Nebraska
– -$129K -2,080 Closed
1 2 3
4
5

RYZB Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in RayzeBio, Inc. Common Stock (RYZB) for Q1 2024, worth a combined $0 — down 100% from $3.41B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of RYZB and 0 opened new positions — a net loss of 106 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Viking Global Investors, exiting entirely with an estimated $413M sold.

  • 0 institutional investors held RayzeBio, Inc. Common Stock (RYZB) as of Q1 2024, down from 107 in Q4 2023.
  • Funds reported $0 of RayzeBio, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new RayzeBio, Inc. Common Stock positions in Q1 2024 and 106 closed out, a net change of -106 holders.
  • The largest RayzeBio, Inc. Common Stock seller in Q1 2024 was Viking Global Investors, an estimated $413M sold.

Based on aggregated 13F filings for Q1 2024.